← All Sponsors
SPONSOR

Ipsen

Total Trials
2
Recruiting
2
Phases
N/A
Conditions studied: Primary Biliary CholangitisNeuroendocrine Tumors
NCT06447168
Recruiting

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

Primary Biliary Cholangitis
United States, Austria, Canada View Trial →
NCT07314164
Recruiting

Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment

Neuroendocrine Tumors
Austria, Germany View Trial →